港股異動 | 五菱汽車(0305.HK)漲超6% 11月宏光MINIEV位居乘用車銷量榜首
格隆匯12月8日丨五菱汽車(0305.HK)漲6.4%,報1.83港元,總市值60.4億港元。上汽通用五菱7日發佈11月銷量快報,全系整體銷量達193000輛,再次摘得民族品牌銷量第一名。其中,GSEV系列車型銷量繼續攀升,當月銷量達50141輛,宏光MINIEV 11月銷量達到45576輛,位居乘用車銷量榜首,同比增長22.1%。與此同時,五菱全球銀標系列持續發力,星辰車型單月銷量達15603輛,首度突破1.5萬大關。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.